Seattle Children’s shared on LinkedIn:
“Featured in Nature.
Seattle Children’s researchers Dr. Beth Lawlor, Dr. Andras Heczey and Dr. Nicholas Vitanza are helping rewrite the future of pediatric cancer care.
Through discoveries that deepen our understanding of solid tumors and advances in engineered cell therapies, they are creating new possibilities for children facing some of the most challenging cancers.
Read more: Rewriting the script for solid tumour therapies.”
Nicholas Vitanza, Scientific Director, Brain Tumor Research Program at Seattle Children’s, added:
“Really honored to speak with Nature about the work being done by our phenomenal research team to bring new targeted cellular therapies to children with brain and spinal cord tumors.”
You can also read: Immuno 2026 Day 5 Highlights: Engineered Cell Therapies, Solid Tumors, and the Future of Pediatric Immunotherapy
